Indications for and timing of liver transplantation

被引:23
作者
Rosen, HR
Shackleton, CR
Martin, P
机构
[1] OREGON HLTH SCI UNIV, PORTLAND VET ADM MED CTR, LIVER TRANSPLANTAT PROGRAM, PORTLAND, OR 97207 USA
[2] UNIV CALIF LOS ANGELES, SCH MED, DEPT SURG, LOS ANGELES, CA 90024 USA
[3] UNIV CALIF LOS ANGELES, CEDARS SINAI MED CTR, LIVER TRANSPLANTAT PROGRAM, LOS ANGELES, CA 90024 USA
[4] UNIV CALIF LOS ANGELES, CTR HLTH SCI, DIV DIGEST DIS, LOS ANGELES, CA 90024 USA
[5] UNIV CALIF LOS ANGELES, CTR HLTH SCI, DUMONT TRANSPLANT PROGRAM, LOS ANGELES, CA 90024 USA
关键词
D O I
10.1016/S0025-7125(05)70480-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The technical success of liver transplantation has led to application of this life-saving procedure to patients with a variety of irreversible acute and chronic liver diseases. The discrepancy between the availability of donor organs and the number of potential liver transplant recipients has continued to worsen, underscoring the key role of the selection and timing processes. The current indications for and contraindications to liver transplantation and the complex variables determining optimal timing are reviewed.
引用
收藏
页码:1069 / +
页数:1
相关论文
共 263 条
[61]  
ERICE A, 1991, REV INFECT DIS, V13, P537
[62]  
ESQUIVEL CO, 1987, SURGERY, V101, P430
[63]  
ESQUIVEL CO, 1988, GASTROENTEROL CLIN N, V17, P167
[64]  
FABRY TL, 1992, GUIDE LIVER TRANSPLA, P79
[65]  
FAGIUOLI S, 1994, ITAL J GASTROENTEROL, V26, P318
[66]   PRIMARY SCLEROSING CHOLANGITIS - LIVER-TRANSPLANTATION OR BILIARY SURGERY [J].
FARGES, O ;
MALASSAGNE, B ;
SEBAGH, M ;
BISMUTH, H .
SURGERY, 1995, 117 (02) :146-155
[67]   CURRENT TREATMENT MODALITIES FOR HEPATOCELLULAR-CARCINOMA [J].
FARMER, DG ;
ROSOVE, MH ;
SHAKED, A ;
BUSUTTIL, RW .
ANNALS OF SURGERY, 1994, 219 (03) :236-247
[68]   OUTCOME OF LIVER-TRANSPLANTATION IN PATIENTS WITH HEMOCHROMATOSIS [J].
FARRELL, FJ ;
NGUYEN, M ;
WOODLEY, S ;
IMPERIAL, JC ;
GARCIAKENNEDY, R ;
MAN, K ;
ESQUIVEL, CO ;
KEEFFE, EB .
HEPATOLOGY, 1994, 20 (02) :404-410
[69]   REFRACTORY ASCITES - EARLY EXPERIENCE IN TREATMENT WITH TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT [J].
FERRAL, H ;
BJARNASON, H ;
WEGRYN, SA ;
RENGEL, GJ ;
NAZARIAN, GK ;
RANK, JM ;
TADAVARTHY, SM ;
HUNTER, DW ;
CASTANEDAZUNIGA, WR .
RADIOLOGY, 1993, 189 (03) :795-801
[70]  
FINGEROTE RJ, 1993, AM J GASTROENTEROL, V88, P1000